include"/home2/www/vhosts/terradaily.com/tdxphp/tdxphp-start.php" ?>
Matsushita says new DNA technology identifies disease risks![]() |
Matsushita, which is best known for its Panasonic brand, said it had developed a technology to electronically identify sequence variations in DNA, called single nucleotide polymorphisms, or SNPs.
It described the technology as a "world-first" that uses artificial DNA dissolved in a solution instead of being attached to an electrode.
"This technology makes it possible to predict individuals' responses to drugs and their risk of developing disease," said the company, which collaborated with Konan University on the project.
"In the future, this technology is expected to enable hospitals or clinics to provide patients with treatments and drugs tailored to their individual physical characteristics," it said.
Community
del.icio.us |
Digg |
Reddit |
YahooMyWeb |
Google |
|
Guangzhou, China (SPX) Aug 20, 2008| The content herein, unless otherwise known to be public domain, are Copyright 1995-2007 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |